Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Teva
Merck
Medtronic
US Department of Justice

Generated: March 25, 2019

DrugPatentWatch Database Preview

Nesher Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for NESHER PHARMS, and what generic and branded alternatives to NESHER PHARMS drugs are available?

NESHER PHARMS has thirty-five approved drugs.

There is one tentative approval on NESHER PHARMS drugs.

Summary for Nesher Pharms
US Patents:0
Tradenames:24
Ingredients:22
NDAs:35

Drugs and US Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms ONDANSETRON ondansetron TABLET, ORALLY DISINTEGRATING;ORAL 077717-001 Jun 25, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 040367-001 Oct 31, 2002 DISCN No No ➤ Sign Up ➤ Sign Up
Nesher Pharms OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 077290-002 Dec 8, 2005 AB RX No No ➤ Sign Up ➤ Sign Up
Nesher Pharms ONDANSETRON ondansetron TABLET, ORALLY DISINTEGRATING;ORAL 077717-002 Jun 25, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Nesher Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076193-001 Feb 7, 2002 DISCN No No ➤ Sign Up ➤ Sign Up
Nesher Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076563-001 Sep 12, 2006 DISCN No No ➤ Sign Up ➤ Sign Up
Nesher Pharms PREDNISOLONE prednisolone SYRUP;ORAL 040423-001 Oct 22, 2001 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Nesher Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nesher Pharms MICRO-K potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-001 Approved Prior to Jan 1, 1982 4,259,315 ➤ Sign Up
Nesher Pharms MICRO-K 10 potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-002 May 14, 1984 4,259,315 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
AstraZeneca
Chinese Patent Office
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.